Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2418752122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Nilima Biswas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of California San Diego, La Jolla, CA 92093. Hauptthemen laut MEDLINE: Cell Proliferation, Choroid, Vascular Endothelial Growth Factor A, Endothelial Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
We hypothesized that a strategy employing tissue-specific endothelial cells (EC) might facilitate the identification of tissue- or organ-specific vascular functions of ubiquitous metabolites. An unbiased approach was employed to identify water-soluble small molecules with mitogenic activity on choroidal EC. We identified adenosine diphosphate (ADP) as a candidate, following biochemical purification from mouse EL4 lymphoma extracts. ADP stimulated the growth of bovine choroidal EC (BCEC) and other bovine or human eye-derived EC. ADP induced rapid phosphorylation of extracellular signal-regulated kinase in a dose- and time-dependent manner. ADP-induced BCEC proliferation could be blocked by pretreatment with specific antagonists of the purinergic receptor P2Y1 but not with a vascular endothelial growth factor (VEGF) inhibitor, indicating that the EC mitogenic effects of ADP are not mediated by stimulation of the VEGF pathway. Intravitreal administration of ADP expanded the neovascular area in a mouse model of choroidal neovascularization. Single-cell transcriptomics from human choroidal datasets show the expression of P2RY1, but not other ADP receptors, in EC with a pattern similar to VEGFR2. Although ADP has been reported to be a growth inhibitor for vascular EC, here we describe its growth-stimulating effects for BCEC and other eye-derived EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of California San Diego, La Jolla, CA 92093.
- Department of Chemistry and Biochemistry, University of California San Diego, La Jolla, CA 92093.
- Department of Physics and Astronomy, Michigan State University, East Lansing, MI 48824.
- Department of Ophthalmology, University of California San Diego, La Jolla, CA 92093.
ORCID-Profile: Nilima Biswas, Hong Xin, Napoleone Ferrara
Förderung
- NEI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Biswas, N., Mori, T., Ragava Chetty Nagaraj, N. K., Xin, H., Diemer, T., Li, P., Su, Y., Piermarocchi, C., & Ferrara, N. (2025). Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2418752122
Vancouver
Biswas N, Mori T, Ragava Chetty Nagaraj NK, Xin H, Diemer T, Li P, et al. Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2418752122
BibTeX
@article{Biswas2025,
author = {Biswas, Nilima and Mori, Tommaso and Ragava Chetty Nagaraj, Naresh Kumar and Xin, Hong and Diemer, Tanja and Li, Pin and Su, Yongxuan and Piermarocchi, Carlo and Ferrara, Napoleone},
title = {Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2418752122}
}
EUVIMED